“The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has approved 45 new two-year grants, from 37 countries, totaling $419.2 million, to fund essential prevention, treatment, and care services provided to the people affected by the three diseases,” according to a Global Fund press release. “Another 11 proposals worth a total of $91.2 million were sent back for revision, and are subject to a further independent technical review before they can be approved,” the press release adds, noting the grant approvals are part of the Transitional Funding Mechanism and “will bridge the financing of essential interventions until the next opportunity to apply for grants” (8/28). According to the U.N. News Centre, the Global Fund “has approved funding of $22.9 billion for more than 1,000 programs in 151 countries, and helped programs provide AIDS treatment for 3.6 million people, anti-tuberculosis treatment for 9.3 million people, and 270 million insecticide-treated nets for the prevention of malaria” (8/28).
Programs, Funding & Financing
UNICEF Official Calls For Increased Investment In Child Mortality To Achieve MDGs; New U.N. Estimates Due Next Month
Mickey Chopra, chief health officer at UNICEF, has called for increased investment in reducing child mortality, the Guardian reports, writing Chopra “said investment now would lead to massive strides in meeting the Millennium Development Goals [MDGs] of reducing maternal deaths by three-quarters (MDG4) and the deaths of children under five by two-thirds (MDG5), both by 2015.” The newspaper adds, “Since 1990, annual maternal deaths have declined by almost half and the deaths of young children have fallen from 12 million to 7.6 million in 2010,” but “many countries — especially in Africa and south Asia — are not making progress” (Tran, 8/28) “Given current trends, the child mortality goal set out by U.N. officials won’t be reached until 2038,” according to U.N. researchers, LiveScience notes.
“According to analysis led by Kanika Bahl and Pooja Shaw of Results for Development’s (R4D’s) Market Dynamics team, improved global incentives and information on cost-effectiveness could save the fight against malaria up to $630 million over the next five years and encourage manufacturers to produce better-performing nets,” Bahl, a managing director for R4D, and Shaw, a program officer in the Market Dynamics Practice at R4D, write in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog. “Using their central position in global [long-lasting insecticide-treated net (LLIN)] markets, donor institutions can introduce policy incentives to focus on cost-effectiveness and rationalize specifications so that suppliers can take advantage of economies of scale in production,” they continue, adding, “To implement these policies, global guidance on the performance of various nets is urgently needed, and this is where organizations such as the WHO can provide direction” (8/27).
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 193 of its “Global Fund Observer.” The issue features an article announcing the Global Fund’s Transitional Funding Mechanism (TFM) decisions; an article reporting the results of the TFM decisions by country; and an article about a new report from the Global Fund Board on challenges in grant implementation, among others (8/27).
In this post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Bill Gates, co-chair of the foundation, reflects on Angola’s success against polio, writing, “Angola marked a full year without a new case of polio” this month, an accomplishment that serves as “the latest evidence that we are extremely close to ending polio forever.” He continues, “Polio is a formidable foe and Angola is one of the world’s poorest nations with numerous health challenges to tackle, which makes Angola’s achievement especially noteworthy,” adding, “Like all 125 countries that have gotten rid of polio since 1988, Angola’s leaders and citizens also deserve the global resolve needed to ensure that no country ever has to go back and re-do the hard, expensive work that’s already been done to protect their children from polio” (8/27).
Small, Ingestible Sensor Can Track Patient Medication Intake, Activity Levels; Technology To Be Tested For TB Treatment
The FDA last month approved for use a small ingestible sensor that, when embedded into a pill, can help “keep track of whether a patient is taking their medicine on time,” Reuters reports. “The digital feedback technology, devised by Redwood City, California-based Proteus Digital Health Inc., can also prompt patients to take their medicine and even ask them to take a walk if they have been inactive for too long,” the news service writes. “Proteus has a partnership with the Bill & Melinda Gates Foundation and China’s Center for Disease Control and Prevention to test the technology in tuberculosis treatment,” Reuters notes, adding, “Pills for anything from the common cold to diabetes or cancer can be embedded.”
The Washington Post examines global efforts to eradicate Guinea worm disease, writing, “The parasitic infection which has sickened millions, mostly in Asia and Africa, is on the verge of being done in not by sophisticated medicine but by aggressive public health efforts in some of the poorest and most remote parts of the world.” According to the newspaper, “hundreds of thousands of volunteers” have contributed to fighting the waterborne parasite, by handing out filtered drinking straws or treating water sources with larvicide, among other efforts. “As a result, the ailment, also known as dracunculiasis, is poised to become the second human disease (the first was smallpox) to be eradicated — and the first to be eliminated without the aid of a vaccine,” the Washington Post continues.
The Global Fund to Fight AIDS, Tuberculosis and Malaria and the Nigerian government on Friday “signed two grant agreements … worth a total of $225 million to support programs that will prevent and treat malaria,” a Global Fund press release reports. According to the press release, the agreements “include an additional $50 million for bed nets, approved in an unusual move by the Global Fund Board that was linked to additional commitments by the government of Nigeria” (8/24). Global Fund Deputy Executive Director Debrework Zewdie “told top government functionaries that the [money] is meant to assure the international community that Nigeria is a worthy partner in the fight to eradicate malaria,” ThisDay writes, adding, “During a transformation of the fund’s grant management structure this year, Nigeria was identified as one of the 20 ‘high impact’ countries that are now receiving special attention” (8/26). Aigboje Aig-Imoukhuede, CEO of Access Bank and chair of the Friends of the Global Fund Africa, “described the grant as [an] opportunity for Nigeria to show leadership and commitment in the fight against malaria by committing more resources to save lives,” the Daily Trust notes (Atonko, 8/26).
Noting “Mitt Romney will become the official nominee for the Republican Party at its convention in Florida” this week, Kim Lufkin, communications officer for the Global Health Technologies Coalition, writes in this post in the coalition’s “Breakthroughs” blog, “Science and research will likely not appear on the agenda, as Romney, expected Vice Presidential candidate Paul Ryan, and others will instead focus on topics like reducing federal spending.” She continues, “It’s unfortunate that research will not be a part of the conversation, as new predictions coming out this week indicate that if Romney and Ryan win the election in November, changes could be coming for health research and efforts to develop much-needed new tools for global health.” She concludes, “It’s important that the candidates — from Obama and Vice President Biden to Romney and Ryan — start talking about these issues head-on,” and “no matter which party takes the White House in November, support for global health [research and development (R&D)] must continue” (8/24).
“The Global Fund to Fight AIDS, Tuberculosis and Malaria [on Monday] released the funding recommendations of its Technical Review Panel for the Transitional Funding Mechanism,” the Stop TB Partnership reports in an article on its webpage. “Grant proposals for tuberculosis (TB) received 25 percent ($127.4 million) of all the approved funding ($510 million) — a marked increase over the historic average share of 16 percent since the Global Fund was established in 2002,” the article notes, adding, “TB applications were also most successful, with an 86 percent recommendation rate; malaria applications engendered a 79 percent recommendation rate and HIV proposals a 62 percent recommendation rate” (8/21).